AtriCure, Inc. (ATRC)Healthcare | Medical Instruments & Supplies | Mason, United States | NasdaqGM
56.87 USD
-0.41
(-0.716%) ⇩
(Oct. 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 5:10 a.m. EDT
The immediate catalyst here is a powerful technical rebound combined with aggressive speculative positioning. After a brutal multi-year grind where the stock lost nearly a third of its value in 2024, the company has staged a remarkable recovery, trading significantly above its 200-day moving average. This reversal is being amplified by a distinct shift in options flow: traders are building a massive wall of call open interest at strikes 60 and 65, effectively betting on a continued rally, while put buyers have largely retreated. Fundamentally, the turnaround story is gaining traction with double-digit revenue growth and improving margins, though the valuation remains stretched with a trailing P/E exceeding 260x. The lack of a dividend payout eliminates income appeal, making this purely a momentum and growth play. While the statistical forecast model offers only a weak lean due to low confidence, the confluence of a recovering price trend, improving operational metrics, and heavy speculative call buying suggests the short-term trend is firmly upward, despite the inherent risks of a small-cap medical device stock. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.051007 |
| AutoTheta | 0.133826 |
| AutoETS | 0.217789 |
| MSTL | 0.225987 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 38% |
| H-stat | 4.61 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.308 |
| Excess Kurtosis | -0.52 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 14.372 |
| Revenue per Share | 11.812 |
| Market Cap | 2,892,766,208 |
| Trailing P/E | 270.81 |
| Forward P/E | 131.04 |
| Beta | 1.25 |
| Profit Margins | 1.85% |
| Website | https://www.atricure.com |
As of Oct. 10, 2026, 5:10 a.m. EDT: Speculators are heavily positioned for upside continuation, evidenced by massive open interest in out-of-the-money calls (strikes 60 and 65) compared to negligible put activity. The call chain shows significant volume at strikes well above the current price, while the put side is virtually dormant, indicating a consensus bet on further appreciation rather than downside protection.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.5468539 |
| Address1 | 7,555 Innovation Way |
| All Time High | 89.18 |
| All Time Low | 1.0 |
| Ask | 49.7 |
| Ask Size | 2 |
| Audit Risk | 5 |
| Average Analyst Rating | 1.9 - Buy |
| Average Daily Volume10 Day | 1,024,030 |
| Average Daily Volume3 Month | 1,088,012 |
| Average Volume | 1,088,012 |
| Average Volume10Days | 1,024,030 |
| Beta | 1.25 |
| Bid | 27.83 |
| Bid Size | 2 |
| Board Risk | 1 |
| Book Value | 10.153 |
| City | Mason |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 3 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 56.87 |
| Current Ratio | 4.218 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 57.98 |
| Day Low | 56.39 |
| Debt To Equity | 14.372 |
| Display Name | AtriCure |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,741,400 |
| Earnings Call Timestamp Start | 1,793,741,400 |
| Earnings Timestamp | 1,793,736,000 |
| Earnings Timestamp End | 1,793,736,000 |
| Earnings Timestamp Start | 1,793,736,000 |
| Ebitda | 33,746,000 |
| Ebitda Margins | 0.05924 |
| Enterprise To Ebitda | 82.949 |
| Enterprise To Revenue | 4.914 |
| Enterprise Value | 2,799,201,024 |
| Eps Current Year | 0.28424 |
| Eps Forward | 0.43398 |
| Eps Trailing Twelve Months | 0.21 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 513 755 4567 |
| Fifty Day Average | 51.0768 |
| Fifty Day Average Change | 5.7931976 |
| Fifty Day Average Change Percent | 0.113421306 |
| Fifty Two Week Change Percent | 54.68539 |
| Fifty Two Week High | 61.7 |
| Fifty Two Week High Change | -4.830002 |
| Fifty Two Week High Change Percent | -0.078282036 |
| Fifty Two Week Low | 25.36 |
| Fifty Two Week Low Change | 31.509998 |
| Fifty Two Week Low Change Percent | 1.2425078 |
| Fifty Two Week Range | 25.36 - 61.7 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,123,248,600,000 |
| Float Shares | 48,827,064 |
| Forward Eps | 0.43398 |
| Forward P E | 131.04291 |
| Free Cashflow | 48,811,500 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 1,350 |
| Fullday Change | -0.40999985 |
| Fullday Change Percent | -0.71578187 |
| Fullday Price | 56.87 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.76298 |
| Gross Profits | 434,608,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03758 |
| Held Percent Institutions | 1.0539601 |
| Implied Shares Outstanding | 50,866,294 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; cryoXT probes, a cryoablation device designed specifically for Cryo Nerve Block therapy; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula's to support access for EPi-Sense catheters. In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio. |
| Long Name | AtriCure, Inc. |
| Market | us_market |
| Market Cap | 2,892,766,208 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_901985 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 10,552,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 3,049,434,325 |
| Number Of Analyst Opinions | 9 |
| Open | 57.6 |
| Operating Cashflow | 64,939,000 |
| Operating Margins | 0.06292 |
| Overall Risk | 2 |
| Payout Ratio | 0.0 |
| Peg Ratio | 10.0 |
| Phone | 513 755 4100 |
| Previous Close | 57.28 |
| Price Eps Current Year | 200.0774 |
| Price Hint | 2 |
| Price To Book | 5.6013002 |
| Price To Sales Trailing12 Months | 5.078396 |
| Profit Margins | 0.01852 |
| Quick Ratio | 3.025 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.9 |
| Region | US |
| Regular Market Change | -0.41 |
| Regular Market Change Percent | -0.715782 |
| Regular Market Day High | 57.98 |
| Regular Market Day Low | 56.39 |
| Regular Market Day Range | 56.39 - 57.98 |
| Regular Market Open | 57.6 |
| Regular Market Previous Close | 57.28 |
| Regular Market Price | 56.87 |
| Regular Market Time | 1,791,921,601 |
| Regular Market Volume | 596,095 |
| Return On Assets | 0.01253 |
| Return On Equity | 0.02151 |
| Revenue Growth | 0.128 |
| Revenue Per Share | 11.812 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 4 |
| Shares Outstanding | 50,866,294 |
| Shares Percent Shares Out | 0.0947 |
| Shares Short | 4,818,782 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 4,141,306 |
| Short Name | AtriCure, Inc. |
| Short Percent Of Float | 0.0986 |
| Short Ratio | 3.2 |
| Source Interval | 15 |
| State | OH |
| Symbol | ATRC |
| Target High Price | 65.0 |
| Target Low Price | 36.0 |
| Target Mean Price | 55.77778 |
| Target Median Price | 57.0 |
| Total Cash | 167,786,000 |
| Total Cash Per Share | 3.299 |
| Total Debt | 74,221,000 |
| Total Revenue | 569,622,016 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.21 |
| Trailing P E | 270.80954 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 36.75735 |
| Two Hundred Day Average Change | 20.112648 |
| Two Hundred Day Average Change Percent | 0.5471735 |
| Type Disp | Equity |
| Volume | 596,095 |
| Website | https://www.atricure.com |
| Zip | 45,040 |